BPC-157 - Valar Peptides
For research use only. Not for human or veterinary use. Not intended to diagnose, treat, cure or prevent any disease.

Free US shipping for orders above $200 • Save 20% on 10-vial bundles

BPC-157

BPC-157

Starting at $38

Independently tested by Novagen Analytical Labs

Batch BPC194522 · HPLC tested 14 May 2026

Verify this batch with the lab View the certificate

Every batch we sell carries its own verification key. This one is NGL-2026-Q0FP2X. Enter it on the laboratory's own website and it returns the certificate for this exact batch. That page belongs to the lab, not to us.

BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide (15 amino acids) derived from research on naturally occurring gastric peptides. It is recognized for its stability and high resistance to enzymatic degradation, making it a valuable compound for controlled laboratory investigation.

BPC-157 has been widely studied in preclinical models for its potential role in:

Tissue regeneration research (muscle, tendon, and epithelial cells),

Gastrointestinal studies, exploring protective effects on gut lining and gastric integrity,

,Angiogenesis and vascular modulation research,

Neuroprotective and anti-inflammatory investigations

These findings support continued interest in understanding BPC-157’s interaction with cellular growth and repair pathways in experimental contexts.

Choose your strength
Choose your quantity

This order qualifies for free US shipping.

In Stock

This material is sold for laboratory research use only. Terms of sale apply. Not for human consumption, nor medical, veterinary, or household uses. Please familiarize yourself with our Terms & Conditions prior to ordering.

Ships from the USADispatched from our United States warehouse
3 to 5 business daysStandard delivery, US wide
International shippingFree on orders over $350
TrackedTracking sent when it leaves the warehouse
Bacteriostatic Water 10ml
Bacteriostatic water3 ml per peptide vial. One 10 ml vial covers three, $11 each. Required to reconstitute.
Add
Title Range Discount
Volume pricing - 10% at 5+, 20% at 10+ 5 - 9 10%
Volume pricing - 10% at 5+, 20% at 10+ 10 + 20%

Data Sheet

Molecular Formula C₆₂H₉₈N₁₆O₂₂
CAS Number 137525-51-0
Molar Mass 1419.54 g/mol
Amino Acid Sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
PubChem CID 9941957
Primary Research Area Cytoprotective, Neuroprotective, Anti-inflammatory
Tissue & Organ Healing/Regeneration
Inflammatory Bowel Disease
Central Nervous System (CNS) Disorders
Cancer (Cachexia)
Pain Management
Alcohol-Induced Adverse Effects
Tendon Healing
Purity ≥98%
Research Summary Description
Multifunctionality and possible medical application of the BPC 157 peptide—literature and patent review Summary: This review article discusses BPC 157's positive effect on general cachexia, a consequence of cancer. Specifically, it notes that BPC 157 (10 μg/mL three times a week i.p.) significantly improved total body weight in the C26 colon adenocarcinoma-induced cancer cachexia mouse model as compared to that of the control group of animals. Tumor volume was lower but not statistically significant.

Citation: Kang, H. M., Lee, B. H., Kim, S. J., Kim, S. H., & Kim, Y. S. (2025). Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review. Molecules, 18(2), 185.
Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblast Summary: This study explored BPC 157's effect on tendon fibroblasts isolated from rat Achilles tendons. It found that BPC 157 dose- and time-dependently increased growth hormone receptor expression at both mRNA and protein levels. Adding growth hormone to BPC 157-treated fibroblasts increased cell proliferation and PCNA expression, activating the Jak2 pathway.

Citation: Chang, C. H., Tsai, Y. G., Hsu, Y. H., & Pang, J. H. (2014). Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts. Molecules, 19(11), 19066–19077.
BPC 157: A novel peptide for the treatment of alcohol-induced gastric and liver lesions Summary: This early report from 2001 provided evidence that BPC 157 (10 mg and 10 ng/kg b.w. i.p. and i.g.) could prevent, attenuate, and reverse gastric and liver lesions induced by chronic alcohol drinking in rats.

Citation: Prkacin, I., Separovic, J., & Sikiric, P. (2001). BPC 157: A novel peptide for the treatment of alcohol-induced gastric and liver lesions. Journal of Physiology-Paris, 95(1-6), 263-268
BPC 157 increases serotonin synthesis in specific brain regions of rats Summary: This study reported that subcutaneous administration of BPC 157 (10 μg/kg/day for 7 days) to rats resulted in brain region-specific increases in serotonin synthesis.

Citation: Tohyama, Y., Sikiric, P., & Diksic, M. (2004). BPC 157 increases serotonin synthesis in specific brain regions of rats. Journal of Physiology-Paris, 98(4-6), 331-336.
Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing Summary: This review found consistently positive and prompt healing effects of BPC-157 for soft tissue damage, including tendon, ligament, and skeletal muscle healing.

Citation: Sikiric, P. C., Seiwerth, S., Rucman, R., Kolenc, D., Vuletic, L. B., Drmic, I.,... & Vukojevic, J. (2019). Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell and Tissue Research, 377(2), 153-167.
Stable gastric pentadecapeptide BPC 157 and wound healing Summary: This review discussed BPC-157's potential in wound healing, including its ability to resolve vessel constriction, primary platelet plug, and fibrin mesh, and its effectiveness in counteracting bleeding disorders and thrombosis. It suggested practical applicability in wound healing, given its ability to simultaneously cure cutaneous and other tissue wounds in rats.

Citation: Sikiric, P. C., Seiwerth, S., Rucman, R., Kolenc, D., Vuletic, L. B., Drmic, I.,... & Vukojevic, J. (2021). Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. Frontiers in Pharmacology, 12, 692015.

Multifunctionality and possible medical application of the BPC 157 peptide—literature and patent review

Summary: This review article discusses BPC 157's positive effect on general cachexia, a consequence of cancer. Specifically, it notes that BPC 157 (10 μg/mL three times a week i.p.) significantly improved total body weight in the C26 colon adenocarcinoma-induced cancer cachexia mouse model as compared to that of the control group of animals. Tumor volume was lower but not statistically significant.

Citation: Kang, H. M., Lee, B. H., Kim, S. J., Kim, S. H., & Kim, Y. S. (2025). Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review. Molecules, 18(2), 185.

Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblast

Summary: This study explored BPC 157's effect on tendon fibroblasts isolated from rat Achilles tendons. It found that BPC 157 dose- and time-dependently increased growth hormone receptor expression at both mRNA and protein levels. Adding growth hormone to BPC 157-treated fibroblasts increased cell proliferation and PCNA expression, activating the Jak2 pathway.

Citation: Chang, C. H., Tsai, Y. G., Hsu, Y. H., & Pang, J. H. (2014). Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts. Molecules, 19(11), 19066–19077.

BPC 157: A novel peptide for the treatment of alcohol-induced gastric and liver lesions

Summary: This early report from 2001 provided evidence that BPC 157 (10 mg and 10 ng/kg b.w. i.p. and i.g.) could prevent, attenuate, and reverse gastric and liver lesions induced by chronic alcohol drinking in rats.

Citation: Prkacin, I., Separovic, J., & Sikiric, P. (2001). BPC 157: A novel peptide for the treatment of alcohol-induced gastric and liver lesions. Journal of Physiology-Paris, 95(1-6), 263-268

BPC 157 increases serotonin synthesis in specific brain regions of rats

Summary: This study reported that subcutaneous administration of BPC 157 (10 μg/kg/day for 7 days) to rats resulted in brain region-specific increases in serotonin synthesis.

Citation: Tohyama, Y., Sikiric, P., & Diksic, M. (2004). BPC 157 increases serotonin synthesis in specific brain regions of rats. Journal of Physiology-Paris, 98(4-6), 331-336.

Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing

Summary: This review found consistently positive and prompt healing effects of BPC-157 for soft tissue damage, including tendon, ligament, and skeletal muscle healing.

Citation: Sikiric, P. C., Seiwerth, S., Rucman, R., Kolenc, D., Vuletic, L. B., Drmic, I.,... & Vukojevic, J. (2019). Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell and Tissue Research, 377(2), 153-167.

Stable gastric pentadecapeptide BPC 157 and wound healing

Summary: This review discussed BPC-157's potential in wound healing, including its ability to resolve vessel constriction, primary platelet plug, and fibrin mesh, and its effectiveness in counteracting bleeding disorders and thrombosis. It suggested practical applicability in wound healing, given its ability to simultaneously cure cutaneous and other tissue wounds in rats.

Citation: Sikiric, P. C., Seiwerth, S., Rucman, R., Kolenc, D., Vuletic, L. B., Drmic, I.,... & Vukojevic, J. (2021). Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. Frontiers in Pharmacology, 12, 692015.

All content and product details on this website are provided solely for informational and educational purposes.

View Cart (0 items)

Your cart is empty

Start Shopping